931 Results

People

  1. Brennan
    Brennan
  2. Vickers
    Vickers
  3. Reuter
    Reuter
  4. Barakat
    Barakat
  5. Soslow
    Soslow
  6. Cordon-Cardo
    Cordon-Cardo
  7. Antonescu
    Antonescu
  8. Herr
    Herr
  9. Alektiar
    Alektiar
  10. Eastham
    Eastham

Groups

  1. Surgery (427)
  2. Department of Pathology and Laboratory Medicine (220)
  3. Department of Medicine (216)
  4. Solid Tumor Oncology Division (172)
  5. Epidemiology and Biostatistics (158)
  6. Urology (134)
  7. Sloan Kettering Institute Faculty (133)
  8. Survivorship Research (128)
  9. GSK Faculty (119)
  10. Molecular Pharmacology and Chemistry Program Faculty (118)
  1. "cancer grading"
Formats
  1. Journal Article (874)
  2. Review (20)
  3. Conference Paper (14)
  4. Editorial (12)
  5. Research Letter (4)
  6. Correspondence (3)
  7. Guidelines (3)
  8. Miscellaneous (1)
Groups
  1. Surgery (427)
  2. Department of Pathology and Laboratory Medicine (220)
  3. Department of Medicine (216)
  4. Solid Tumor Oncology Division (172)
  5. Epidemiology and Biostatistics (158)
  6. Urology (134)

More Groups

People
  1. Murray Brennan (57)
  2. Andrew Vickers (44)
  3. Robert Soslow (44)
  4. Victor Reuter (43)
  5. Peter Scardino (41)
  6. Richard Barakat (37)

More People

Years
  1. 2025 (22)
  2. 2024 (58)
  3. 2023 (31)
  4. 2022 (30)
  5. 2021 (13)
  6. 2020 (44)

More Years

Publications
  1. Cancer (59)
  2. Gynecologic Oncology (42)
  3. American Journal of Surgical Pathology (38)
  4. Annals of Surgical Oncology (35)
  5. Journal of Urology (34)
  6. Journal of Clinical Oncology (33)

More Publications

Publishers
  1. Elsevier Inc. (139)
  2. Elsevier Science, Inc. (103)
  3. Wiley Blackwell (99)
  4. Springer (93)
  5. Lippincott Williams & Wilkins (90)
  6. American Association for Cancer Research (38)

More Publishers

Results (931)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Oudard, S.; Negrier, S.; Szczylik, C.; Pili, R.; Bjarnason, G. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A propensity score–matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer
    Journal Article

    Magnoni, F.; Corso, G.; Maisonneuve, P.; Massari, G.; Alberti, L.; Castelnovo, G.; Leonardi, M. C.; Sacchini, V.; Galimberti, V.; Veronesi, P.
    Journal of Cancer Research and Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Removing the designation of cancer from grade group 1 disease will do more good than harm
    Editorial

    Vickers, A. J.; Cooperberg, M. R.; Eggener, S. E.
    European Urology (2023)

    Fulltext@MSK | Save
  • Prostate adenocarcinoma grade group 1: Rationale for retaining a cancer label in the 2022 World Health Organization Classification
    Editorial

    Netto, G. J.; Amin, M. B.; Compérat, E. M.; Gill, A. J.; Hartmann, A.; Moch, H.; Menon, S.; Raspollini, M. R.; Rubin, M. A.; Srigley, J. R.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Gross total resection of spinal chondrosarcoma is associated with improved locoregional relapse-free survival and overall survival
    Journal Article

    Abunimer, A. M.; Hammoudeh, L.; Dee, E. C.; Lak, A. M.; Chi, J.; Lu, Y.; Groff, M.; Shin, J. H.; Lam, M. B.; Zaidi, H. A.
    European Spine Journal (2023)

    Fulltext@MSK | Save
  • Histopathologic grading is of prognostic significance in primary angiosarcoma of breast: Proposal of a simplified 2-tier grading system
    Journal Article

    Kuba, M. G.; Dermawan, J. K.; Xu, B.; Singer, S.; Plitas, G.; Tap, W. D.; D'Angelo, S. P.; Rosenbaum, E.; Brogi, E.; Antonescu, C. R.
    American Journal of Surgical Pathology (2023)

    Fulltext@MSK | Save
  • Should grade group 1 prostate cancer be reclassified as “non-cancer”? A pathology community perspective
    Editorial

    Zhou, M.; Amin, A.; Fine, S. W.; Rao, P.; Siadat, F.; Shah, R. B.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis
    Journal Article

    Brasky, T. M.; Hade, E. M.; Cohn, D. E.; Newton, A. M.; Petruzella, S.; O'Connell, K.; Bertrand, K. A.; Cook, L. S.; De Vivo, I.; Du, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials
    Journal Article

    Boone, R. M.; Praiss, A. M.; Huang, Y.; Melamed, A.; Khoury-Collado, F.; Hou, J. Y.; Gockley, A.; St. Clair, C. M.; Hershman, D. L.; Wright, J. D.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to long-term survivors
    Journal Article

    Kahn, R.; Filippova, O.; Gordhandas, S.; An, A.; Straubhar, A. M.; Zivanovic, O.; Gardner, G. J.; O'Cearbhaill, R. E.; Tew, W. P.; Grisham, R. N.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save